APOE Genotype in the Era of Disease-Modifying Treatment with Monoclonal Antibodies Against Amyloid-β
(2023) In JAMA Neurology 80(12). p.1269-1271
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/72f4c6ed-9d27-4bbe-81a1-f758b85c3ca7
- author
- Ossenkoppele, Rik LU and Van Der Flier, Wiesje M.
- organization
- publishing date
- 2023-12
- type
- Contribution to journal
- publication status
- published
- subject
- in
- JAMA Neurology
- volume
- 80
- issue
- 12
- pages
- 3 pages
- publisher
- American Medical Association
- external identifiers
-
- scopus:85179680245
- pmid:37930662
- ISSN
- 2168-6149
- DOI
- 10.1001/jamaneurol.2023.4046
- language
- English
- LU publication?
- yes
- id
- 72f4c6ed-9d27-4bbe-81a1-f758b85c3ca7
- date added to LUP
- 2024-01-03 11:35:31
- date last changed
- 2024-06-27 15:24:08
@misc{72f4c6ed-9d27-4bbe-81a1-f758b85c3ca7,
author = {{Ossenkoppele, Rik and Van Der Flier, Wiesje M.}},
issn = {{2168-6149}},
language = {{eng}},
number = {{12}},
pages = {{1269--1271}},
publisher = {{American Medical Association}},
series = {{JAMA Neurology}},
title = {{APOE Genotype in the Era of Disease-Modifying Treatment with Monoclonal Antibodies Against Amyloid-β}},
url = {{http://dx.doi.org/10.1001/jamaneurol.2023.4046}},
doi = {{10.1001/jamaneurol.2023.4046}},
volume = {{80}},
year = {{2023}},
}